Literature DB >> 7378057

The inhibition of macrophage protein turnover by a selective inhibitor of thiol proteinases.

E Shaw, R T Dean.   

Abstract

1. A new inhibitor of thiol proteinases, benzyloxycarbonylphenylalanylalanine diazomethyl ketone (benzyloxycarbonylphenylalanylalanyldiazomethane, Z-Phe-Ala-CHN2) was added to cultured mouse peritoneal macrophages prelabelled with [14C]leucine. The degradation of protein was studied under conditions of basal proteolysis in the presence of 10% pig serum. After a lag of about 6 h a time- and dose-dependent inhibition of protein degradation was observed, up to a maximum of about 40%. 2. The inhibitor entered the cells with kinetics consistent with entry by pinocytosis, giving access to the lysosomal system. 3. Intracellular cathepsin B was almost completely inactivated after 90 min of exposure of the culture to 0.1 mm-inhibitor. 4. The inhibition of proteolysis and of cathepsin B was reversed virtually completely within 24 h, when the inhibitor was removed from the medium. Since the inhibitor forms a covalent bond with the enzyme, the recovery of cathepsin B activity presumably reflects production of new molecules of active enzyme. 5. The inhibitory effects of pepstatin, the carboxyl proteinase inhibitor, were under some circumstances additive with those Z-Phe-Ala-CHN2, and were also largely reversible. 6. It is concluded that thiol proteinases play a major role in lysosomal proteolysis in cultured macrophages.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7378057      PMCID: PMC1161587          DOI: 10.1042/bj1860385

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

Review 1.  Lysosomes.

Authors:  R T Dean; A J Barrett
Journal:  Essays Biochem       Date:  1976       Impact factor: 8.000

2.  Direct evidence of importance of lysosomes in degradation of intracellular proteins.

Authors:  R T Dean
Journal:  Nature       Date:  1975-10-02       Impact factor: 49.962

3.  Membrane transport by macrophages in suspension and adherent to glass.

Authors:  J F Pofit; P R Strauss
Journal:  J Cell Physiol       Date:  1977-08       Impact factor: 6.384

4.  Control of cell protein degradation. Changes in activities of lysosomal proteases.

Authors:  J S Amenta; M J Sargus; F M Baccino
Journal:  Biochim Biophys Acta       Date:  1977-06-03

Review 5.  Intracellular protein degradation in mammalian and bacterial cells: Part 2.

Authors:  A L Goldberg; A C St John
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

6.  A new assay for cathepsin B1 and other thiol proteinases.

Authors:  A J Barrett
Journal:  Anal Biochem       Date:  1972-05       Impact factor: 3.365

7.  Inactivation of cathepsin B1 by diazomethyl ketones.

Authors:  R Leary; E Shaw
Journal:  Biochem Biophys Res Commun       Date:  1977-12-07       Impact factor: 3.575

8.  Cathepsin L. A new proteinase from rat-liver lysosomes.

Authors:  H Kirschke; J Langner; B Wiederanders; S Ansorge; P Bohley
Journal:  Eur J Biochem       Date:  1977-04-01

9.  Diazomethyl ketone substrate derivatives as active-site-directed inhibitors of thiol proteases. Papain.

Authors:  R Leary; D Larsen; H Watanabe; E Shaw
Journal:  Biochemistry       Date:  1977-12-27       Impact factor: 3.162

10.  Secretion of a specific collagenase by stimulated macrophages.

Authors:  Z Werb; S Gordon
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

View more
  24 in total

1.  Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice.

Authors:  X Bi; A P Yong; J Zhou; C E Ribak; G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  Proteolytic processing and glycosylation of cathepsin B. The role of the primary structure of the latent precursor and of the carbohydrate moiety for cell-type-specific molecular forms of the enzyme.

Authors:  L Mach; K Stüwe; A Hagen; C Ballaun; J Glössl
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

3.  Investigation of the role of calpain as a stimulus-response mediator in human platelets using new synthetic inhibitors.

Authors:  J Anagli; J Hagmann; E Shaw
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

4.  Inhibitor studies indicate that active cathepsin L is probably essential to its own processing in cultured fibroblasts.

Authors:  A Salminen; M M Gottesman
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

5.  Inhibition of the presentation of dengue virus antigen by macrophages to B cells by serine-protease inhibitors.

Authors:  N Rizvi; U C Chaturvedi; A Mathur
Journal:  Int J Exp Pathol       Date:  1991-02       Impact factor: 1.925

6.  Ubiquitin-protein conjugates accumulate in the lysosomal system of fibroblasts treated with cysteine proteinase inhibitors.

Authors:  F J Doherty; N U Osborn; J A Wassell; P E Heggie; L Laszlo; R J Mayer
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

7.  The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor.

Authors:  R W Mason; D Wilcox; P Wikstrom; E N Shaw
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

8.  Distinct proteolytic mechanisms in serum-sufficient and serum-restricted fibroblasts. Transformed 3T3 cells fail to regulate proteolysis in relation to culture density only during serum-sufficiency.

Authors:  S M Cockle; R T Dean
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

9.  Characterization of Ayu17-449 gene expression and resultant kidney pathology in a knockout mouse model.

Authors:  Hua Tang; Kimi Araki; Zhenghua Li; Kenichi Yamamura
Journal:  Transgenic Res       Date:  2008-02-21       Impact factor: 2.788

10.  Presentation of cartilage proteoglycan to a T cell hybridoma derived from a mouse with proteoglycan-induced arthritis.

Authors:  F R Brennan; G Negroiu; E I Buzás; C Fülöp; K Holló; K Mikecz; T T Glant
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.